PD 089828
CAS No. 179343-17-0
PD 089828 ( PD-089828; PD089828 )
Catalog No. M23806 CAS No. 179343-17-0
PD 089828 is a competitive inhibitor of the receptor tyrosine kinases FGFR1, PDGFRβ, and EGFR (IC50s = 0.15, 1.76, and 5.47 μM, respectively) and a noncompetitive inhibitor of the nonreceptor tyrosine kinase c-Src (IC50 = 0.18 μM)
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 65 | In Stock |
|
10MG | 110 | In Stock |
|
25MG | 237 | In Stock |
|
50MG | 354 | In Stock |
|
100MG | 518 | In Stock |
|
500MG | 1098 | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePD 089828
-
NoteResearch use only, not for human use.
-
Brief DescriptionPD 089828 is a competitive inhibitor of the receptor tyrosine kinases FGFR1, PDGFRβ, and EGFR (IC50s = 0.15, 1.76, and 5.47 μM, respectively) and a noncompetitive inhibitor of the nonreceptor tyrosine kinase c-Src (IC50 = 0.18 μM)
-
DescriptionPD 089828 is a competitive inhibitor of the receptor tyrosine kinases FGFR1, PDGFRβ, and EGFR (IC50s = 0.15, 1.76, and 5.47 μM, respectively) and a noncompetitive inhibitor of the nonreceptor tyrosine kinase c-Src (IC50 = 0.18 μM)
-
SynonymsPD-089828; PD089828
-
PathwayAngiogenesis
-
TargetEGFR
-
RecptorEGFR;FGFR1;PDGFRβ
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number179343-17-0
-
Formula Weight405.3
-
Molecular FormulaC18H18Cl2N6O
-
Purity>98% (HPLC)
-
SolubilityDMSO:2.5 mM
-
SMILESCC(C)(C)NC(=O)NC1=C(C=C2C=NC(=NC2=N1)N)C3=C(C=CC=C3Cl)Cl
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Dahring TK, et al. Inhibition of growth factor-mediated tyrosine phosphorylation in vascular smooth muscle by PD 089828, a new synthetic protein tyrosine kinase inhibitor. J Pharmacol Exp Ther. 1997 Jun;281(3):1446-56.
molnova catalog
related products
-
EGFR/ErbB2 Inhibitor
EGFR/ErbB2 Inhibitor is a cell-permeable inhibitor of EGFR and c-ErbB2 (IC50s = 20 and 79 nM, respectively)
-
Naquotinib mesylate
Naquotinib (ASP-8273) is a potent, irreversible, mutant-selective inhibitor of EGFR.
-
Epidermal Growth Fac...
Epidermal Growth Factor?binds to epidermal growth factor receptor (EGFR) and stimulates cell growth and proliferation. It is approved for the treatment of diabetic foot ulcers.